New York

The Cannabis Society has built a deal making conference platform for high growth cannabis founders/C-Suite executives, investors and service providers to transact. We recently hosted a sold-out Invite Only Cannabis Business Conference on Tuesday, February 19th at One Penn Plaza in NYC.  

The conference, in partnership with Zuber, Lawler, & Del Luca and WVC Holdings Inc., featured multiple speakers and cannabis entrepreneurs sharing valuable industry insights. Along with two keynotes, there were a series of panel discussions covering relevant topics including sources of capital, CBD & Hemp, and product innovation.

Tom Zuber of Zuber Lawler & Del Duca LLP

Tom Zuber of Zuber Lawler & Del Duca LLP

“The challenges are the opportunities.”

This statement came from our first keynote Tom Zuber, Founder and Managing Partner of Zuber Lawler & Del Duca LLP. Mr. Zuber is at the cutting edge of cannabis patent and trademark law. He has advised some of the most iconic companies in the world on their patent and trademark portfolios. He holds a law degree from Columbia Law School, a Master’s degree in Public Policy from Harvard University, and a biomedical engineering degree from Rutgers.

Zuber Lawler & Del Duca LLP has offices in New York, Chicago, Los Angeles and Silicon Valley.  The Cannabis Society will be hosting our [Invite Only] Cannabis Business Conference at Zuber Lawler’s Los Angeles office this coming Monday, March 25th. Register here for the event.

The second keynote was given by Paul Hennessey of WVC Holdings Inc., and Chief Business Development Officer of Contract Pharmacal Corporation. Paul has decades of experience, working with many world renowned healthcare brands and leads the strategic direction and business integration of CPC and its many partners.

CPC, founded in 1971, is a contract development and manufacturing organization focused on OTC and Rx drug products as well as nutraceuticals. CPC maintains strong relationships with hundreds of customers globally and has commercialized more than five thousand products worldwide.  It comes as no surprise CPC would eventually eye hemp as the next major health and wellness ingredient.

Paul Hennessey of Contract Pharmacal Corp. and WVC Holdings Inc.

Paul Hennessey of Contract Pharmacal Corp. and WVC Holdings Inc.

Paul’s informative keynote touched on navigating the compliance requirements of retail products and gave us a detailed overview of WVC Holdings Inc. current products and investments.

About: WVC Holdings Inc.

WVC Holdings Inc. is a healthcare investment firm investing across the healthcare sector at all stages of company development, with a special emphasis on the discovery and development of innovative therapeutics in nutraceuticals.  CEO of Contract Pharmacal Corp., Matt Wolf, assembled a team with deep investment, operating, marketing and scientific expertise to form WVCH. Currently WVCH is building a synergistic portfolio of distinct and complementary businesses to capitalize on the opportunities presented in the cannabis industry.

One of WVCH’s current investments is ULEVA™, a hemp supplement line targeted for mass market retailers. Expected to launch in Q3 given the recent passing of the 2018 Farm Bill, Uleva is currently available online.  Uleva is comprised of six unique formulas, each one combining hemp with specific herbal and nutritive ingredients to provide the ultimate hemp-based support for a healthier lifestyle.

Photo from  Uleva.com

Photo from Uleva.com

One of the six offerings is ULEVA™ FUEL, an herbal supplement combining the caffeinated power of green tea extract with full spectrum hemp extract, offering its users an herbal boost when they need it the most. FUEL is rich in phytocannabinoids to help support your body’s endocannabinoid system.*

At $35.99USD for 30 capsules, Uleva’s product line is comparably priced with most dietary supplements on the market. As a special treat for our readers, use code “TCS20” at checkout at uleva.com for 20% discount on ULEVA™ products.

WVCH’s cannabis portfolio also includes:

  • Cultivarian Brands: A line of THC-containing products launching in recreational US states over the next 12-24 months.

  • Ascent: WVCH’s hemp extraction lab based in South Carolina.

  • Botannis Labs: A testing lab business that offers regulatory compliance consulting.

  • Kindred Wolf: Strategic marketing and creative agency focused on the cannabis industry.

The Cannabis Society Cannabis Business Conference featured speakers from WVCH’s Kindred Wolf agency, including Rich Roginski, VP of Operations, and Nick Kingsbury, Regulatory Compliance Director.

Some of our panels and panelists at our February 19th cannabis conference included:

Investments in Cannabis Panel w/ Zuber Lawler, Art Assets, Welcan Capital and Phyto Partners

Investments in Cannabis Panel [Right to Left: Evan Schnurmacher, Barb Paley, Tom Zube, Vikas Desai]

Investments in Cannabis Panel [Right to Left: Evan Schnurmacher, Barb Paley, Tom Zube, Vikas Desai]

Barbara (Bobbi) Koz Paley, CEO and Founder of Art Assets LLC. Barbara has a proven track record of identifying cultural shifts, investing early and creating connections across multiple industries and sectors. She has established herself as an early player in real estate, art and cannabis before they were asset classes.  Barbara and her son Jamie Koz, whom has decades of experience in cannabis cultivation, originally opened four micro-growers in LA, joined ArcView’s global network of leading investors and entrepreneurs, and established an evolving ecosystem among investments, makers and fellow investors.

Vikas Desai, Founder and Investor and Partner at WelCan Capital, a venture capital firm focused on the cannabis industry. With an emphasis on seed investing, WelCan is looking to align with experienced entrepreneurs solving key problems that exist in the industry.

Evan Schnurmacher, Analyst at Phyto Partners. Evan is a University of Maryland graduate and began his career in the film industry. He recently joined Phyto Partners, a marijuana investment fund, as a Junior Analyst. Phyto Partners makes equity and debt investments in emerging early stage and operating businesses in the cannabis industry. Evan’s role includes deal flow intake, researching investments targets and attending industry conferences to establish a presence and network in the cannabis industry.

Product Innovation Panel w/ The NACB, Etain Health LLC, Urbania Investment Group, and Cherry LLC

Eugene Morgulis, Director of Legal & Strategic Initiatives, National Association of Cannabis Businesses. Eugene oversees the creation of the NACB’s National Standards and heads up its Symposium program.

About: The National Association of Cannabis Businesses (NACB)

A NACB membership lets the cannabis industry know that you’re trustworthy, responsible, and compliant. The NACB is the only association in the US cannabis industry that vets its members. They function as a self-governing community whom strive to be recognized as the most legitimate, professional, and trustworthy businesses in the industry. The members recognize this is the best path in the face of regulatory uncertainty faced by cannabis professionals currently and in the future.  For more information on the NACB membership program, click here.

Amy K. Peckham, CEO and Co-Founder of Etain LLC. Amy and her daughters have established NY’s only women-owned medical marijuana business. Etain is a family run business committed to  manufacturing clean, safe and consistent medical marijuana products for the patients of New York. Etain, LLC is one of the first five vertically integrated registered organizations providing medical marijuana products under the New York Compassionate Care Act enacted July 2014 by Governor Andrew M. Cuomo. Current retail locations: NYC, Yonkers, Kingston and Syracuse.

Derek Pellizzari, CEO and Director for Urbania Investment Group.With over 26 years of experience specializing in business development, Derek has a successful track record leading both mid and large sized companies to achieve their revenue goals through effective cost management, marketing and sales. He was previously VP, Sales and Marketing at Rubicon Organics, which has been a publicly traded cannabis LP since 2015 in Washington, California and Canada. Derek is currently a partner and managing director at Kika Marketing and Communications Inc., a full-service marketing, design and web agency with an international reach and offices in Vancouver, Montreal and Manila.

Barry Bordetsky, Cherry LLC Chief Legal Advisor. Barry has brought his litigation background into the cannabis space, representing individuals, public and privately held entities, brokerage firms and registered representatives in state and federal courts, as well as arbitration forums, throughout the country. Barry's extensive litigation and securities experience provides Cherry LLC with yet another diversified outlook. Barry combines his experience as a commercial and securities litigator with his background as a former general counsel of a publicly traded company to provide Cherry LLC with an understanding and preparation for legal obstacles that the cannabis industry notoriously experiences.

WVC Holdings, Inc. Panel

The WVCH panel on CBD and Hemp

The WVCH panel on CBD and Hemp

WVCH held their own panel at The Cannabis Society Business Conference which discussed CBD and Hemp and included WVCH President Sam Potter. WVCH strives to capitalize on their team’s decades of experience to positively affect the energized cannabis industry and deliver products that will make a difference in people’s lives. For more information on WVC Holdings, Inc. check out their deck here.

As mentioned above, use promo code “TCS20” for 20% off ULEVA™ products at uleva.com.

The Cannabis Society has lots of exciting cannabis business conferences this spring in the USA

If you’re interested in being a speaker, sponsor, or attendee at The Cannabis Society’s upcoming conferences, reach out to General Manager, Jay Cleary at manager@thecannabissociety.org.



*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Always check with your physician before starting a new dietary supplement program.